BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37714937)

  • 1. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    Ji D; Zhong R; Fan S
    Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel necroptosis signature for predicting survival in lung adenocarcinoma.
    Zang K; Wang M; Zhu X; Yao B; Huang Y
    BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma.
    Li M; Deng X; Zhou D; Liu X; Dai J; Liu Q
    Curr Genomics; 2024 Feb; 25(1):26-40. PubMed ID: 38544827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
    Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma.
    Wang G; Liu X; Liu H; Zhang X; Shao Y; Jia X
    Sci Rep; 2023 Sep; 13(1):15345. PubMed ID: 37714937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
    BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer.
    Zheng L; Lin L; Song J; Huang S; Chen L; Li H; Ma N; Chen Q; Chen Y
    Cent Eur J Immunol; 2023; 48(1):14-25. PubMed ID: 37206585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential.
    Zhang W; Yan Y; Peng J; Thakur A; Bai N; Yang K; Xu Z
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612282
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.